ICARES Medicus, Inc. (TPEX:6612)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
107.00
-1.00 (-0.93%)
Aug 12, 2025, 1:30 PM CST
-0.93%
Market Cap4.60B
Revenue (ttm)996.44M
Net Income (ttm)127.40M
Shares Out42.57M
EPS (ttm)2.97
PE Ratio36.38
Forward PEn/a
Dividend0.30 (0.28%)
Ex-Dividend DateAug 22, 2025
Volume25,098
Average Volume29,923
Open107.00
Previous Close108.00
Day's Range106.00 - 107.00
52-Week Range88.50 - 177.00
Beta0.51
RSI25.88
Earnings DateAug 12, 2025

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments... [Read more]

Sector Healthcare
Founded 2011
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6612
Full Company Profile

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.

Financial Statements

News

There is no news available yet.